Phenolic acid concentrations in plasma and urine from men consuming green or black tea and potential chemopreventive properties for colon cancer

Molecular Nutrition and Food Research

Volumn 57, Issue 3, 2013, Pages 483-493

  Henning, Susanne M ^a   Wang, Piwen ^a,b   Abgaryan, Narine ^a   Vicinanza, Roberto ^a   de Oliveira, Daniela Moura ^c   Zhang, Yanjun ^a   Lee, Ru Po ^a   Carpenter, Catherine L ^a   Aronson, William J ^d   Heber, David ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b CHARLES R DREW UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Black tea; EGCG; Green tea; HCT116 colon cancer cells; Phenolic metabolites

Indexed keywords

( ) 5 (3',4',5' DIHYDROXYPHENYL) VALEROLACTONE; (-)-5-(3',4',5'-DIHYDROXYPHENYL)-VALEROLACTONE; 3 HYDROXYPHENYLACETIC ACID; 3 O METHYLGALLIC ACID; 3,4 DIHYDROXYPHENYLACETIC ACID; 3-HYDROXYPHENYLACETIC ACID; 3-O-METHYLGALLIC ACID; 4 HYDROXYPHENYLACETIC ACID; 4-HYDROXYPHENYLACETIC ACID; ANTINEOPLASTIC AGENT; CATECHIN; DRUG DERIVATIVE; EPIGALLOCATECHIN GALLATE; GALLIC ACID; HIPPURIC ACID; HIPPURIC ACID DERIVATIVE; HYDROXYBENZOIC ACID DERIVATIVE; LACTONE; PHENOLIC ACID; PHENYLACETIC ACID DERIVATIVE;

AGED; ARTICLE; BLOOD; CAMELLIA SINENSIS; CELL PROLIFERATION; CELL STRAIN HCT116; CHEMISTRY; COLON TUMOR; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET THERAPY; DRUG EFFECT; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MALE; MIDDLE AGED; PROSTATE TUMOR; RANDOMIZED CONTROLLED TRIAL; TEA; URINE;

3,4-DIHYDROXYPHENYLACETIC ACID; AGED; ANTICARCINOGENIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CAMELLIA SINENSIS; CATECHIN; CELL PROLIFERATION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; COLONIC NEOPLASMS; GALLIC ACID; HCT116 CELLS; HIPPURATES; HUMANS; HYDROXYBENZOATES; LACTONES; MALE; MIDDLE AGED; PHENYLACETATES; PROSTATIC NEOPLASMS; TEA;

CAMELLIA SINENSIS;

EID: 84875054374     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.201200646     Document Type: Article

References (46)

1. Sharma, V., Rao, L. J., A thought on the biological activities of black tea. Crit. Rev. Food Sci. Nutr. 2009, 49, 379-404.
2. Hodgson, J. M., Morton, L. W., Puddey, I. B., Beilin, L. J. et al., Gallic acid metabolites are markers of black tea intake in humans. J. Agric. Food Chem. 2000, 48, 2276-2280.
3. Kuhnert, N., Drynan, J. W., Obuchowicz, J., Clifford, M. N. et al., Mass spectrometric characterization of black tea thearubigins leading to an oxidative cascade hypothesis for thearubigin formation. Rapid Commun. Mass Spectrom. 2010, 24, 3387-3404.
4. Mulder, T. P., van Platerink, C. J., Wijnand Schuyl, P. J., Van Amelsvoort, J. M., Analysis of theaflavins in biological fluids using liquid chromatography-electrospray mass spectrometry. J. Chromatogr. B Biomed. Sci. Appl. 2001, 760, 271-279.
5. Li, C., Meng, X., Winnik, B., Lee, M. J. et al., Analysis of urinary metabolites of tea catechins by liquid chromatography/electrospray ionization mass spectrometry. Chem. Res. Toxicol. 2001, 14, 702-707.
6. Li, C., Lee, M. J., Sheng, S., Meng, X. et al., Structural identification of two metabolites of catechins and their kinetics in human urine and blood after tea ingestion. Chem. Res. Toxicol. 2000, 13, 177-184.
7. Chen, H., Parks, T. A., Chen, X., Gillitt, N. D. et al., Structural identification of mouse fecal metabolites of theaflavin 3, 3'-digallate using liquid chromatography tandem mass spectrometry. J. Chromatogr. A 2011, 1218, 7297-7306.
8. Henning, S. M., Choo, J. J., Heber, D., Nongallated compared with gallated flavan-3-ols in green and black tea are more bioavailable. J. Nutr. 2008, 138, 1529S-1534S.
9. Lambert, J. D., Sang, S., Yang, C. S., Biotransformation of green tea polyphenols and the biological activities of those metabolites. Mol. Pharm. 2007, 4, 819-825.
10. Wang, P., Aronson, W. J., Huang, M., Zhang, Y. et al., Green tea polyphenols and metabolites in prostatectomy tissue: implications for cancer prevention. Cancer Prev. Res. (Phila) 2010, 3, 985-993.
11. Yang, C. S., Wang, X., Lu, G., Picinich, S. C., Cancer prevention by tea: animal studies, molecular mechanisms and human relevance. Nat. Rev. Cancer 2009, 9, 429-439.
12. Bohn, S. K., Ward, N. C., Hodgson, J. M., Croft, K. D., Effects of tea and coffee on cardiovascular disease risk. Food Funct. 2012, 3, 575-591.
13. Arab, L., Liu, W., Elashoff, D., Green and black tea consumption and risk of stroke: a meta-analysis. Stroke 2009, 40, 1786-1792.
14. Gao, K., Xu, A., Krul, C., Venema, K. et al., Of the major phenolic acids formed during human microbial fermentation of tea, citrus, and soy flavonoid supplements, only 3, 4-dihydroxyphenylacetic acid has antiproliferative activity. J. Nutr 2006, 136, 52-57.
15. Olthof, M. R., Hollman, P. C., Buijsman, M. N., van Amelsvoort, J. M. et al., Chlorogenic acid, quercetin-3-rutinoside and black tea phenols are extensively metabolized in humans. J. Nutr. 2003, 133, 1806-1814.
16. Siegel, R., Naishadham, D., Jemal, A., Cancer statistics, 2012. CA Cancer J. Clin. 2012, 62, 10-29.
17. Pan, M. H., Lai, C. S., Wu, J. C., Ho, C. T., Molecular mechanisms for chemoprevention of colorectal cancer by natural dietary compounds. Mol. Nutr. Food Res. 2011, 55, 32-45.
18. O'Keefe, S. J., Nutrition and colonic health: the critical role of the microbiota. Curr. Opin. Gastroenterol. 2008, 24, 51-58.
19. Davis, C. D., Milner, J. A., Gastrointestinal microflora, food components and colon cancer prevention. J. Nutr. Biochem. 2009, 20, 743-752.
20. Jenner, A. M., Rafter, J., Halliwell, B., Human fecal water content of phenolics: the extent of colonic exposure to aromatic compounds. Free Radic. Biol. Med. 2005, 38, 763-772.
21. Henning, S. M., Niu, Y., Lee, N. H., Thames, G. D. et al., Bioavailability and antioxidant activity of tea flavanols after consumption of green tea, black tea, or a green tea extract supplement. Am. J. Clin. Nutr. 2004, 80, 1558-1564.
22. Hudthagosol, C., Haddad, E. H., McCarthy, K., Wang, P. et al., Pecans acutely increase plasma postprandial antioxidant capacity and catechins and decrease LDL oxidation in humans. J. Nutr. 2011, 141, 56-62.
23. Penner, N., Ramanathan, R., Zgoda-Pols, J., Chowdhury, S., Quantitative determination of hippuric and benzoic acids in urine by LC-MS/MS using surrogate standards. J. Pharm. Biomed. Anal. 2010, 52, 534-543.
24. Sang, S., Lee, M. J., Yang, I., Buckley, B. et al., Human urinary metabolite profile of tea polyphenols analyzed by liquid chromatography/electrospray ionization tandem mass spectrometry with data-dependent acquisition. Rapid Commun. Mass Spectrom. 2008, 22, 1567-1578.
25. Singleton, V. L., Esau, P., Phenolic substances in grapes and wine, and their significance. Adv. Food Res. 1969, Suppl 1, 1-261.
26. Neilson, A. P., Hopf, A. S., Cooper, B. R., Pereira, M. A. et al., Catechin degradation with concurrent formation of homo- and heterocatechin dimers during in vitro digestion. J. Agric. Food Chem. 2007, 55, 8941-8949.
27. Reenilä, I., Tuomainen, P., Mannisto, P. T., Improved assay of reaction products to quantitate catechol-O-methyltransferase activity by high-performance liquid chromatography with electrochemical detection. J. Chromatogr. B Biomed. Appl. 1995, 663, 137-142.
28. Lee, M. J., Maliakal, P., Chen, L., Meng, X. et al., Pharmacokinetics of tea catechins after ingestion of green tea and (-)- epigallocatechin-3-gallate by humans: formation of different metabolites and individual variability. Cancer Epidemiol. Biomarkers Prev. 2002, 11, 1025-1032.
29. Del, R. D., Calani, L., Cordero, C., Salvatore, S. et al., Bioavailability and catabolism of green tea flavan-3-ols in humans. Nutrition 2010, 26, 1110-1116.
30. Yuan, J. M., Gao, Y. T., Yang, C. S., Yu, M. C., Urinary biomarkers of tea polyphenols and risk of colorectal cancer in the Shanghai Cohort Study. Int. J. Cancer 2007, 120, 1344-1350.
31. Sun, C. L., Yuan, J. M., Lee, M. J., Yang, C. S. et al., Urinary tea polyphenols in relation to gastric and esophageal cancers: a prospective study of men in Shanghai, China. Carcinogenesis 2002, 23, 1497-1503.
32. Sanchez-Patan, F., Chioua, M., Garrido, I., Cueva, C. et al., Synthesis, analytical features, and biological relevance of 5-(3', 4'-dihydroxyphenyl)-gamma-valerolactone, a microbial metabolite derived from the catabolism of dietary flavan-3-ols. J. Agric. Food Chem. 2011, 59, 7083-7091.
33. Phipps, A. N., Stewart, J., Wright, B., Wilson, I. D., Effect of diet on the urinary excretion of hippuric acid and other dietary-derived aromatics in rat. A complex interaction between diet, gut microflora and substrate specificity. Xenobiotica 1998, 28, 527-537.
34. Roowi, S., Stalmach, A., Mullen, W., Lean, M. E. et al., Green tea flavan-3-ols: colonic degradation and urinary excretion of catabolites by humans. J. Agric. Food Chem. 2010, 58, 1296-1304.
35. Holmes, E., Loo, R. L., Stamler, J., Bictash, M. et al., Human metabolic phenotype diversity and its association with diet and blood pressure. Nature 2008, 453, 396-400.
36. Salek, R. M., Maguire, M. L., Bentley, E., Rubtsov, D. V. et al., A metabolomic comparison of urinary changes in type 2 diabetes in mouse, rat, and human. Physiol. Genomics 2007, 29, 99-108.
37. Calvani, R., Miccheli, A., Capuani, G., Tomassini, M. A. et al., Gut microbiome-derived metabolites characterize a peculiar obese urinary metabotype. Int. J. Obes. (Lond.) 2010, 34, 1095-1098.
38. Clifford, M. N., Copeland, E. L., Bloxsidge, J. P., Mitchell, L. A., Hippuric acid as a major excretion product associated with black tea consumption. Xenobiotica 2000, 30, 317-326.
39. Schantz, M., Erk, T., Richling, E., Metabolism of green tea catechins by the human small intestine. Biotechnol. J. 2010, 5, 1050-1059.
40. Lee, H. C., Jenner, A. M., Low, C. S., Lee, Y. K., Effect of tea phenolics and their aromatic fecal bacterial metabolites on intestinal microbiota. Res. Microbiol. 2006, 157, 876-884.
41. van Dorsten, F. A., Daykin, C. A., Mulder, T. P., van Duynhoven, J. P., Metabonomics approach to determine metabolic differences between green tea and black tea consumption. J. Agric. Food Chem. 2006, 54, 6929-6938.
42. Long, L. H., Kirkland, D., Whitwell, J., Halliwell, B., Different cytotoxic and clastogenic effects of epigallocatechin gallate in various cell-culture media due to variable rates of its oxidation in the culture medium. Mutat. Res. 2007, 634, 177-183.
43. Miene, C., Weise, A., Glei, M., Impact of polyphenol metabolites produced by colonic microbiota on expression of COX-2 and GSTT2 in human colon cells (LT97). Nutr. Cancer 2011, 63, 653-662.
44. Bai, H. W., Shim, J. Y., Yu, J., Zhu, B. T., Biochemical and molecular modeling studies of the O-methylation of various endogenous and exogenous catechol substrates catalyzed by recombinant human soluble and membrane-bound catechol-O-methyltransferases. Chem. Res. Toxicol. 2007, 20, 1409-1425.
45. Nagai, M., Conney, A. H., Zhu, B. T., Strong inhibitory effects of common tea catechins and bioflavonoids on the O-methylation of catechol estrogens catalyzed by human liver cytosolic catechol-O-methyltransferase. Drug Metab. Dispos. 2004, 32, 497-504.
46. Zhu, B. T., Wang, P., Nagai, M., Wen, Y. et al., Inhibition of human catechol-O-methyltransferase (COMT)-mediated O-methylation of catechol estrogens by major polyphenolic components present in coffee. J. Steroid Biochem. Mol. Biol. 2009, 113, 65-74.